Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study

Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study

(2020) Joyce Wing Yan Mak et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

The Role of the Status of Selected Micronutrients in Shaping the Immune Function

(2019) Ibrahim Elmadfa et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study

(2019) Sanjay K Murthy et al.   GUT

Ulcerative colitis

(2017) Ryan Ungaro et al.   LANCET

Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease

(2016) David J Gracie et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis

(2016) Shailja C. Shah et al.   Clinical Gastroenterology and Hepatology

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis

(2016) Stefanos Bonovas et al.   Clinical Gastroenterology and Hepatology

Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease

(2016) Aida Kapic Lunder et al.   GASTROENTEROLOGY

Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC

(2016) Jean-Frédéric Colombel et al.   GUT

Mortality and Causes of Death in Ulcerative Colitis

(2016) Øistein Hovde et al.   INFLAMMATORY BOWEL DISEASES

Folic Acid Supplementation May Reduce Colorectal Cancer Risk in Patients With Inflammatory Bowel Disease

(2016) Nick E. Burr et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission

(2016) Jae Hyun Kim et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis

(2016) Xinyun Qiu et al.   Oncotarget

Review article: the histological assessment of disease activity in ulcerative colitis

(2015) A. Marchal Bressenot et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mesalamine, but Not Sulfasalazine, Reduces the Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease

(2015) Anthony OʼConnor et al.   INFLAMMATORY BOWEL DISEASES

Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study

(2015) Manuel Barreiro-de Acosta et al.   Journal of Crohns & Colitis

Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case–Control Study

(2013) David T. Rubin et al.   Clinical Gastroenterology and Hepatology

Comparison of demographic and clinical characteristics of patients with early vs. adult vs. late onset ulcerative colitis

(2013) İsmail Hakkı Kalkan et al.   European Journal of Internal Medicine

Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study

(2013) Cloé Charpentier et al.   GUT

5-Aminosalicylic Acid Is Not Protective Against Colorectal Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Non-Referral Populations

(2012) Geoffrey C Nguyen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

(2012) Stephen J Halpin et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Standard errors of non-standardised and age-standardised relative survival of cancer patients

(2011) L Jansen et al.   BRITISH JOURNAL OF CANCER

Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis

(2011) Sandro Ardizzone et al.   Clinical Gastroenterology and Hepatology

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

(2011) Jean Frédéric Colombel et al.   GASTROENTEROLOGY

Ulcerative Colitis

(2011) Silvio Danese et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patients With Late-Adult-Onset Ulcerative Colitis Have Better Outcomes Than Those With Early Onset Disease

(2010) Christina Y. Ha et al.   Clinical Gastroenterology and Hepatology

Do Patients with Ulcerative Colitis Diagnosed at a Young Age Have More Severe Disease Activity than Patients Diagnosed when Older?

(2010) Jin Ha Lee et al.   DIGESTION

Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Long-term outcome after infliximab for refractory ulcerative colitis

(2008) Marc Ferrante et al.   Journal of Crohns & Colitis

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

(2008) Inger Camilla Solberg et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY